R. Fischer-colbrie, A. Laslop, and R. Kirchmair, Secretogranin II: Molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin, Progress in Neurobiology, vol.46, issue.1, pp.49-70, 1995.
DOI : 10.1016/0301-0082(94)00060-U

H. Winkler and R. Fischer-colbrie, The chromogranins A and B: The first 25 years and future perspectives, Neuroscience, vol.49, issue.3, pp.497-528, 1992.
DOI : 10.1016/0306-4522(92)90222-N

K. Helle, The granin family of uniquely acidic proteins of the diffuse neuroendocrine system: comparative and functional aspects, Biological Reviews, vol.266, issue.4, pp.769-794, 2004.
DOI : 10.1016/S0167-4838(97)00137-4

M. Guerin, J. Guillemot, E. Thouennon, A. Pierre, and F. El-yamani, Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma, Regulatory Peptides, vol.165, issue.1, pp.21-29, 2010.
DOI : 10.1016/j.regpep.2010.06.003

E. Zhao, D. Zhang, A. Basak, and V. Trudeau, New insights into granin-derived peptides: evolution and endocrine roles, General and Comparative Endocrinology, vol.164, issue.2-3, pp.161-174, 2009.
DOI : 10.1016/j.ygcen.2009.01.011

P. Rosa and H. Gerdes, The granin protein family: Markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors, Journal of Endocrinological Investigation, vol.85, issue.3, pp.207-225, 1994.
DOI : 10.1172/JCI114604

L. Taupenot, K. Harper, O. Connor, and D. , The Chromogranin???Secretogranin Family, New England Journal of Medicine, vol.348, issue.12, pp.1134-1149, 2003.
DOI : 10.1056/NEJMra021405

L. Ferrari, E. Seregni, E. Bajetta, A. Martinetti, and E. Bombardieri, The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours, Anticancer Res, vol.19, pp.3415-3427, 1999.

O. Connor, D. Deftos, and L. , Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms, New England Journal of Medicine, vol.314, issue.18, pp.1145-1151, 1986.
DOI : 10.1056/NEJM198605013141803

E. Baudin, J. Bidart, A. Bachelot, M. Ducreux, and D. Elias, Impact of chromogranin A measurement in the work-up of neuroendocrine tumors, Annals of Oncology, vol.12, issue.2suppl, pp.79-82, 2001.
DOI : 10.1023/A:1012494309486

L. Guignat, J. Bidart, M. Nocera, E. Comoy, and M. Schlumberger, Chromogranin A and the ?? -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma, British Journal of Cancer, vol.84, issue.6, pp.808-812, 2001.
DOI : 10.1054/bjoc.2000.1677

R. Cunningham, K. Pogue, W. Curry, C. Johnston, and J. Sloan, Immunostaining for vasostatin I distinguishes between ileal and lung carcinoids, The Journal of Pathology, vol.381, issue.3, pp.321-325, 1999.
DOI : 10.7326/0003-4819-120-4-199402150-00008

K. Sekiya, M. Ghatei, M. Salahuddin, A. Bishop, and Q. Hamid, Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value., Journal of Clinical Investigation, vol.83, issue.6, pp.1834-1842, 1989.
DOI : 10.1172/JCI114089

D. Yasuda, H. Iguchi, A. Funakoshi, H. Wakasugi, and K. Sekiya, Comparison of Plasma Pancreastatin and GAWK Concentrations, Presumed Processing Products of Chromogranin A and B, in Plasma of Patients with Pancreatic Islet Cell Tumors, Hormone and Metabolic Research, vol.25, issue.11, pp.593-595, 1993.
DOI : 10.1055/s-2007-1002184

D. Vieau, A. Rojas-miranda, J. Verley, F. Lenne, and X. Bertagna, The secretory granule peptides 7B2 and CCB are sensitive biochemical markers of neuro-endocrine bronchial tumours in man, Clinical Endocrinology, vol.43, issue.4, pp.319-325, 1991.
DOI : 10.1007/BF02890062

U. Eder, R. Fischer-colbrie, P. Kogner, B. Leitner, and P. Bjellerup, Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas, Neuroscience Letters, vol.253, issue.1, pp.17-20, 1998.
DOI : 10.1016/S0304-3940(98)00588-6

R. Ischia, R. Gasser, R. Fischer-colbrie, U. Eder, and A. Pagani, Levels and Molecular Properties of Secretoneurin-Immunoreactivity in the Serum and Urine of Control and Neuroendocrine Tumor Patients, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.1, pp.355-360, 2000.
DOI : 10.1210/jc.85.1.355

R. Ischia, A. Hobisch, R. Bauer, U. Weiss, and R. Gasser, ELEVATED LEVELS OF SERUM SECRETONEURIN IN PATIENTS WITH THERAPY RESISTANT CARCINOMA OF THE PROSTATE, The Journal of Urology, vol.163, issue.4, pp.1161-1164, 2000.
DOI : 10.1016/S0022-5347(05)67714-2

H. Neumann, B. Bausch, S. Mcwhinney, B. Bender, and O. Gimm, Germ-Line Mutations in Nonsyndromic Pheochromocytoma, New England Journal of Medicine, vol.346, issue.19, pp.1459-1466, 2002.
DOI : 10.1056/NEJMoa020152

D. Karasek, Z. Frysak, and K. Pacak, Genetic Testing for Pheochromocytoma, Current Hypertension Reports, vol.3, issue.Suppl 5, pp.456-464, 2010.
DOI : 10.1093/qjmed/77.2.1151

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061287/pdf

E. Thouennon, A. Pierre, J. , Y. L. Eisenhofer, and G. , Genetic markers for the diagnosis and prognosis of pheochromocytoma, Expert Review of Endocrinology & Metabolism, vol.103, issue.1, pp.45-52, 2009.
DOI : 10.1007/BF01938677

A. Vicha, Z. Musil, and K. Pacak, Genetics of pheochromocytoma and paraganglioma syndromes, Current Opinion in Endocrinology & Diabetes and Obesity, vol.20, issue.3, pp.186-191, 2013.
DOI : 10.1097/MED.0b013e32835fcc45

L. Amar, J. Bertherat, E. Baudin, C. Ajzenberg, and B. Bressac-de-paillerets, Genetic Testing in Pheochromocytoma or Functional Paraganglioma, Journal of Clinical Oncology, vol.23, issue.34, pp.8812-8818, 2005.
DOI : 10.1200/JCO.2005.03.1484

K. Andersen, R. Altaf, A. Krarup-hansen, B. Kromann-andersen, and T. Horn, Malignant pheochromocytomas and paragangliomas ??? The importance of a multidisciplinary approach, Cancer Treatment Reviews, vol.37, issue.2, pp.111-119, 2011.
DOI : 10.1016/j.ctrv.2010.07.002

Y. Anouar, S. Jegou, D. Alexandre, I. Lihrmann, and J. Conlon, Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides, FEBS Letters, vol.66, issue.3, pp.295-299, 1996.
DOI : 10.1046/j.1471-4159.1996.66062248.x

Y. Anouar, C. Desmoucelles, Y. L. Leprince, J. Breault, and L. , Identification of a novel secretogranin II-derived peptide (SgII 187?252 ) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide, J Clin Endocrinol Metab, vol.83, pp.2944-2951, 1998.

J. Guillemot, D. Ait-ali, V. Turquier, M. Montero-hadjadje, and A. Fournier, Involvement of multiple signaling pathways in PACAP-induced EM66 secretion from chromaffin cells, Regulatory Peptides, vol.137, issue.1-2, pp.79-88, 2006.
DOI : 10.1016/j.regpep.2006.04.023

M. Montero-hadjadje, G. Pelletier, Y. L. Li, S. Guillemot, and J. , Biochemical Characterization and Immunocytochemical Localization of EM66, a Novel Peptide Derived from Secretogranin II, in the Rat Pituitary and Adrenal Glands, Journal of Histochemistry & Cytochemistry, vol.60, issue.8, pp.1083-1095, 2003.
DOI : 10.1074/jbc.275.17.12553

J. Guillemot, Y. Anouar, M. Montero-hadjadje, E. Grouzmann, and L. Grumolato, Circulating EM66 is a highly sensitive marker for the diagnosis and follow-up of pheochromocytoma, International Journal of Cancer, vol.24, issue.8, pp.2003-2012, 2006.
DOI : 10.1001/jama.288.3.314

J. Guillemot, E. Thouennon, M. Guerin, V. Vallet-erdtmann, and A. Ravni, Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66, Journal of Molecular Endocrinology, vol.48, issue.2, pp.115-127, 2012.
DOI : 10.1530/JME-11-0077

L. Yon, J. Guillemot, M. Montero-hadjadje, L. Grumolato, and J. Leprince, Malignant Tumors, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2579-2585, 2003.
DOI : 10.1210/jc.2002-021748

M. Montero-hadjadje, H. Vaudry, V. Turquier, J. Leprince, D. Rego et al., Localization and characterization of evolutionarily conserved chromogranin A-derived peptides in the rat and human pituitary and adrenal glands, Cell and Tissue Research, vol.310, issue.2, pp.223-236, 2002.
DOI : 10.1007/s00441-002-0625-9

J. Guillemot, P. Compagnon, D. Cartier, E. Thouennon, and C. Bastard, Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors, Endocrine Related Cancer, vol.16, issue.1, pp.281-290, 2009.
DOI : 10.1677/ERC-08-0190

J. Conlon, B. Hamberger, and L. Grimelius, Isolation of peptides arising from the specific posttranslational processing of chromogranin A and chromogranin B from human pheochromocytoma tissue, Peptides, vol.13, issue.4, pp.639-644, 1992.
DOI : 10.1016/0196-9781(92)90167-2

W. Curry, C. Shaw, C. Johnston, L. Thim, and K. Buchanan, Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour, FEBS Letters, vol.288, issue.3, pp.319-321, 1992.
DOI : 10.1016/0014-5793(88)80606-9

C. Gleeson, W. Curry, C. Johnston, and K. Buchanan, Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia, Journal of Endocrinology, vol.151, issue.3, pp.409-420, 1996.
DOI : 10.1677/joe.0.1510409

F. Hanna, J. Ardill, C. Johnston, R. Cunningham, and W. Curry, Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid, Journal of Endocrinology, vol.152, issue.2, pp.275-281, 1997.
DOI : 10.1677/joe.0.1520275

A. Heaney, W. Curry, K. Pogue, V. Armstrong, and M. Mirakhur, Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas, Pituitary, vol.3, issue.2, pp.67-75, 2000.
DOI : 10.1023/A:1009949623054

M. Herbomez, G. Forzy, C. Bauters, C. Tierny, and P. Pigny, An analysis of the biochemical diagnosis of 66 pheochromocytomas, European Journal of Endocrinology, vol.156, issue.5, pp.569-575, 2007.
DOI : 10.1530/EJE-06-0640

M. Stridsberg, B. Eriksson, K. Oberg, and E. Janson, A comparison between three commercial kits for chromogranin A measurements, Journal of Endocrinology, vol.177, issue.2, pp.337-341, 2003.
DOI : 10.1677/joe.0.1770337

S. Sanduleanu, D. Bruine, A. Stridsberg, M. Jonkers, D. Biemond et al., Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy, European Journal of Clinical Investigation, vol.104, issue.9, pp.802-811, 2001.
DOI : 10.1210/jc.84.8.2712

M. Stridsberg, K. Oberg, Q. Li, U. Engstrom, and G. Lundqvist, Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours, Journal of Endocrinology, vol.144, issue.1, pp.49-59, 1995.
DOI : 10.1677/joe.0.1440049

K. Borch, M. Stridsberg, P. Burman, and J. Rehfeld, Basal Chromogranin a and Gastrin Concentrations in Circulation Correlate to Endocrine Cell Proliferation in Type-A Gastritis, Scandinavian Journal of Gastroenterology, vol.110, issue.3, pp.198-202, 1997.
DOI : 10.3109/00365517209081114

A. Spadaro, A. Ajello, C. Morace, A. Zirilli, D. Arrigo et al., Serum chromogranin-A in hepatocellular carcinoma: Diagnostic utility and limits, World Journal of Gastroenterology, vol.11, issue.13, pp.1987-1990, 2005.
DOI : 10.1007/0-306-46837-9_28

F. Nobels, D. Kwekkeboom, W. Coopmans, C. Schoenmakers, and J. Lindemans, Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones, J Clin Endocrinol Metab, vol.82, pp.2622-2628, 1997.

B. Loo, J. Marniemi, and A. Jula, Evaluation of multiplex immunoassays, used for determination of adiponectin, resistin, leptin, and ghrelin from human blood samples, in comparison to ELISA assays, Scandinavian Journal of Clinical and Laboratory Investigation, vol.150, issue.3, pp.221-226, 2011.
DOI : 10.1210/en.2009-0697

Y. Kim, S. Bae, I. Kim, H. Liu, and H. Bang, Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer, Oncology Reports, vol.28, issue.2, pp.585-591, 2012.
DOI : 10.3892/or.2012.1829

R. Därr, C. Pamporaki, M. Peitzsch, K. Miehle, and A. Prejbisz, Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions, Clinical Endocrinology, vol.411, issue.4, 2013.
DOI : 10.1016/j.cca.2010.01.012

H. Neumann, Imaging vs Biochemical Testing for Pheochromocytoma, JAMA: The Journal of the American Medical Association, vol.288, issue.3, pp.314-315, 2002.
DOI : 10.1001/jama.288.3.314

A. Sawka, A. Gafni, L. Thabane, W. Young, and . Jr, The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2859-2866, 2004.
DOI : 10.1210/jc.2003-031127